EMPAGLIFLOZIN

Clinical trials for EMPAGLIFLOZIN explained in plain language.

Never miss a new study

Get alerted when new EMPAGLIFLOZIN trials appear

Sign up with your email to follow new studies for EMPAGLIFLOZIN, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1 Completed 1

New hope to stop liver failure: two drugs better than one?

Disease control Recruiting now

This study is testing if adding the diabetes/heart drug empagliflozin to the standard heart drug carvedilol can better protect people with liver cirrhosis and a stiff heart. The main goal is to see if this combination prevents serious liver complications (like internal bleeding o…

Matched conditions: EMPAGLIFLOZIN

Phase: PHASE4 • Sponsor: Post Graduate Institute of Medical Education and Research, Chandigarh • Aim: Disease control

Last updated Mar 25, 2026 14:09 UTC

EMPAGLIFLOZIN

Get alerted when new EMPAGLIFLOZIN trials appear

New hope to stop liver failure: two drugs better than one?